IBSA at the EFIC Congress, Dubrovnik, September 2016

IBSA at the EFIC Congress, Dubrovnik,
September 2016

As a leading company in the field of OA and Pain, IBSA gladly announces its participation in the EFIC Congress with a Satellite Symposium focusing on the use of glycosaminoglycans (GAGs) in the management of OA, namely:

  • pharmaceutical grade chondroitin sulfate (CS)
  • highly purified hyaluronic acid for i.a. injection (HA)

from their structure to the clinical benefits. New data about the “hybrid cooperative complexes” of HA will be also presented.


See the full programme here.

All people interested in knowing more about IBSA and its pipeline of products (Condrosulf/chondroitin sulphate; Sinovial/i.a. HA; Flector/diclofenac epolamine; Akis-Dicloin/subcutaneous diclofenac) are also invited to visit us in the exhibition hall.

Published on

2016 © IBSA Institut Biochimque SA - All rights reserved

This website uses cookies to help us give you the best experience when you visit. By using this website you consent to our use of these cookies. Find out more about how we use cookies and how to manage them by reading our cookie notice. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.